Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.

By O. Hermine, F. Lefrère, J. Bronowicki, X. Mariette, K. Jondeau, V. Eclache-Saudreau, B. Delmas, F. Valensi, P. Cacoub, C. Bréchot and 2 more. New England Journal of Medicine, 2002

944 citations recorded by the source corpus.

Subfields: Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/406bc1b7fe4608e19b91eecfcb85081dd0f28f62

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pathology and Forensic Medicine

Citations in the corpus

Mechanisms of B-cell lymphoma pathogenesis (2005, background): “Importantly, treatment of several patients with HCV-associated splenic B-cell lymphomas with anti-viral interferon therapy not only eliminated the virus, but also caused regression of the lymphom”
Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (2019, background): “(33,37,98-110) Successful treatment also confers improvement in extrahepatic manifestations of HCV disease, including cryoglobulinemic vasculitis(111-116) and HCV-related non-Hodgkin lymphoma and other lymphoproliferative disorders,(117-125) as well as improved productivity and quality of life.”
The tetraspanin web modulates immune-signalling complexes (2005, background): “Indeed, it has been found that treatments of HCV-infected lymphoma patients with antiviral drugs that eliminate the virus can lead to regression of the lymphom”